Explore the full record of transactions filed by Cordova Ashley, Chief Financial Officer. Director active across 1 companies, notably NovoCure Ltd. Cumulatively, 13 disclosures have been logged. Total volume traded: €280k. The latest transaction was filed on 3 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Ashley Cordova serves as the Chief Financial Officer at NovoCure Ltd. She oversees the company's financial management, including budgeting and risk management. Cordova brings expertise in finance and accounting, contributing to strategic decisions that promote NovoCure's growth and sustainability. Her commitment to financial transparency enhances trust among investors and stakeholders.